JUPW
JUPW company profile
Latest price
As of — · Market data by Massive
Market cap
—
Volume
—
Previous close
—
Day range
—
Listed
—
Coverage
9 articles
Price performance
Recent trading
Newsroom
Latest JUPW coverage

SRM Entertainment Files S-1 Registration for Spin-Off from Jupiter Wellness
Jupiter Wellness, Inc. (Nasdaq: JUPW), announced today that SRM Entertainment, Inc. (SRM) has filed a registration statement with the Securities and Exchange Commission to separate the company from Jupiter Wellness, Inc. (Jupiter Wellness). Upon completion of the spin-off, SRM and Jupiter Wellness will be two independent and separate public companies. Jupite

Jupiter Wellness Approved for Dual Listing on Upstream
Jupiter Wellness, Inc. (Nasdaq: JUPW), announced today its approval to dual list its shares on Upstream, the revolutionary trading app for digital securities and NFTs.

Jupiter Wellness Issues Letter to Shareholders and Corporate Update
Jupiter Wellness, Inc. (NASDAQ:JUPW), issued a Letter to Shareholders today to provide a corporate update since its last report in September.

Eris Oaknet Healthcare and Cosmofix Technovation Announce Market Launch of Jupiter Wellness’s Photocil Products for Indian Market
Jupiter Wellness, Inc. announced that Eris Oaknet Healthcare Pvt Ltd (Eris Oaknet) and Cosmofix Technovation Pvt Ltd (Cosmofix) had market launch meetings for Photocil products for the Indian market. The Eris Oaknet product is branded as “Photofirst” in India.

Jupiter Wellness Re-Opens Enrollment in Clinical Trial Comparison of JW-100 and EUCRISA for the Treatment of Eczema
Jupiter Wellness, Inc. (Nasdaq:JUPW), announced today that it has re-opened enrollment in a clinical trial aimed at evaluating the superiority of JW-100, a novel cannabidiol topical cream, in a head-to-head study against EUCRISA, an FDA Approved topical treatment for eczema developed by Pfizer.

Jupiter Wellness Announces Plan to Spin Off Caring Brands, Inc. as Digital Securities Dividend to Shareholders
Jupiter Wellness, Inc. (Nasdaq:JUPW), today announced that it has plans to transfer and spin-off forty percent (40%) of the Company's wholly-owned subsidiary, Caring Brands, Inc., by way of a dividend in the form of digital securities to Jupiter Wellness shareholders with a record date to occur in late November.

CDSCO India equivalent to US FDA approves Photocil for Sale
Jupiter Wellness, Inc. (Nasdaq: JUPW), has been approved by the CDSCO for sale in India. The Central Drugs Standard Control Organisation (CDSCO), under the Directorate General of Health Services, Ministry of Health & Family Welfare, is the National Regulatory Authority (NRA) of India.

Jupiter Wellness Initiates Clinical Trial for Potential New Treatment for Tinnitus
Jupiter Wellness announced the initiation of a triple-blinded clinical study evaluating a possible treatment for tinnitus. To date, no effective treatment exists for tinnitus.

Jupiter Wellness Announces Notice of Allowance for Minoxidil Adjuvant Therapies U.S. Patent
Jupiter Wellness announced that the United States Patent and Trademark Office (USPTO) has granted a notice of allowance for patent application No. 16/747,685, titled "Minoxidil Adjuvant Therapies."